Applied Health Economics and Health Policy

Title Publication Date Language Citations
Authors’ Reply to Hays: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance”2020/03/23English
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis2022/02/25English
Analytical strategies for characterizing chemotherapy diffusion with patient-level population-based data2010/01/01English
Healthcare costs in renal transplant recipients using branded versus generic ciclosporin2010/01/01English
A Pharmacoeconomic analysis of compliance gains on antipsychotic medications2008/10/01English
Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis2010/01/01English
Ongoing pharmaceutical reforms in France2010/01/01English
Community-based interventions to promote increased physical activity2008/10/01English
Inpatient costs of endophthalmitis evaluated for the whole of France2010/01/01English
The authors’ reply2010/01/01English
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France2008/10/01English
Does extending health insurance coverage to the uninsured improve population health outcomes?2008/10/01English
Cost-effectiveness analysis of entecavir versus lamivudine in the first-line treatment of Australian patients with chronic hepatitis B2008/10/01English
Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit2012/09/01English
Current and Future Economic Burden of Osteoporosis in New Zealand2011/01/01English
Acknowledgement2005/01/01English
Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)2022/06/20English
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective2022/09/22English
VOLY: The Monetary Value of a Life-Year at the End of Patients’ Lives2023/10/04English
Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review2023/09/25English
The Inflation Reduction Act: Hope for Prescription Drug Prices in the USA2023/10/06English
What About Offering a Financial Incentive Directly to Clinical Units to Encourage the Use of Biosimilars? Results of a Two-Year National Experiment in France2023/05/30English
Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life2023/05/27English
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals2022/12/19English
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia2022/07/18English
Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?2024/02/08English
Authors’ Reply to Gandjour: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”2023/12/02English
Health Service Utilisation of People Living with Psychosis: Validity of Self-report Compared with Administrative Data in a Randomised Controlled Trial2023/11/21English
Comment on: “The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022”2023/11/16English
Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA2023/11/01English